QART Co-founder & CSO Recent Publication in Nature Photonics
Raanana, Israel – QART Medical is honored to share that Professor Natan T. Shaked, co-founder and Chief Scientific Officer of QART Medical and Chair of the department of biomedical engineering at Tel Aviv University, has published a paper in Nature Photonics titled “Label-free Biomedical Optical Imaging”. This paper explores various label-free optical imaging technologies, which are non-destructive approaches to visualizing biomedical samples for both research and clinical diagnosis.
Among other topics, this paper reviews the advanced technologies that are implemented in QART’s flagship device, the Q300™. The Q300™ is a breakthrough solution that uses quantitative phase microscopy (QPM) to provide IVF (in vitro fertilization) clinicians with real time, objective, and quantitative morphological information on individual cells and is now in clinical outcome studies.
The paper can be found at the following link: https://www.nature.com/articles/s41566-023-01299-6
About QART Medical
QART Medical is an ISO13485 certified MedTech company addressing the global infertility epidemic. To do so, QART has developed the Q300™, a breakthrough solution to male infertility issues that provides a quantitative characterization of sperm cell morphology to facilitate informed clinical decision making when selecting cells for use in in-vitro fertilization (IVF). QART aims to improve current success rates of Intra-Cytoplasmic Sperm Injection (ICSI) by quantitatively characterizing the morphology and composition of individual sperm cells with 3D topographic imaging. The Q300™ is registered with the US FDA and is in the process of CE-Mark registration and Israeli regulatory registration for commercial sales.